Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
accommodate, analyst, ASC, ASU, authoritative, Azimuth, Black, bundled, Bundling, Carlo, carryback, chain, chapter, CIGIM, Codification, Cottrell, counterclaim, cycle, declaratory, deconsolidated, departure, desegregation, discretion, Eastern, EMA, Epidemiological, ER, establishedin, extrapolated, floor, franchise, genetic, graph, hour, Hypoparathyroidsim, inclusion, incorrect, inequitable, INO, Interactive, JD, Jeppesen, latitude, lecturer, MA, Medicademy, Medicaid, MHLW, MicroCap, Ministry, Missouri, Monte, Nordisk, Novo, Nucynta, occasionally, online, pattern, peer, Pennsylvania, PhD, PMDA, prevalence, proceed, proceeding, promptly, properly, prototype, prove, pump, question, rarity, rational, RDG, rehabilitation, reinvestment, rhPTH, sanctioned, Sandra, sector, Seventeen, simulation, singularly, speculate, Stratemeier, suboptimal, subset, Subtopic, Temple, Thirty, thyroid, Topic, tranche, TSR, undelivered, unfavorable, uninfringed, unissued, validly, vi, Web, Welfare
Removed:
allegedly, Allergan, APB, appointed, aspect, assignment, asymptomatic, attribute, Austria, backdating, BI, Boehringer, Bulletin, burn, calculating, cancelled, capitalized, carryover, cell, cognitive, compensatory, creating, depression, divert, diverted, drop, dysfunction, EMEA, Emerging, employed, Emulsion, encouraged, endeavor, enlarged, equaled, equitable, excrete, false, felt, fiduciary, FIFO, FIN, flexibility, footnote, forma, founded, gland, GmbH, hypercalcemic, impacting, incompatible, indefinitely, indenture, informed, Ingelheim, initiate, injectable, injunctive, insufficiency, internationally, interpretation, Jackson, layer, leave, leveraging, loan, mature, measuring, misleading, neuropsychiatric, Ophthalmic, opposition, original, Ortho, overactive, Pharmaceutica, plant, pro, promising, provincial, purpose, refinement, refundable, regimen, reportable, reprice, reprioritizing, repurchasing, revised, routine, SAB, scheduling, secreting, shortfall, stay, sue, target, Task, thereunder, toxicity, traded, turnover, ultimate, unamortized, underway, utility, variety, Vetter, violated
Filing tables
Filing exhibits
- 10-K Annual report
- 10.31 Agreement for Sale and Assignment of Rights, Dated February 26, 2010, Between NPS Pharmaceuticals, Inc. and LSRC II S.?R.L.
- 12.1 Computation Ratio of Earnings Available to Cover Fixed Charges
- 21.1 Subsidiaries
- 23.1 Consent
- 31.1 CEO 302 Cetificate
- 31.2 CEO 302 Cetificate
- 32.1 906 Certificate
- PDF 10-K
- 10.31 Agreement for Sale and Assignment of Rights, Dated February 26, 2010, Between NPS Pharmaceuticals, Inc. and LSRC II S.?R.L.
- 12.1 Computation Ratio of Earnings Available to Cover Fixed Charges
- 21.1 Subsidiaries
- 23.1 Consent
- 31.1 CEO 302 Cetificate
- 31.2 CEO 302 Cetificate
- 32.1 906 Certificate
- COVER Cover
Related press release
NPSP similar filings
Filing view
External links
NPS PHARMACEUTICALS, INC.
550 Hills Drive, 3rd Floor
Bedminster, New Jersey 07921
March 11, 2010
Securities and Exchange Commission
Washington, D.C. 20549
Ladies and Gentlemen:
Pursuant to the requirements of the Securities Exchange Act of 1934, we are transmitting herewith the attached Form 10-K for the year ended December 31, 2009.
Sincerely,
NPS PHARMACEUTICALS, INC.
Michael J. Golembiewski
Corporate Controller